How well do you know about immunomodulators in rheumatoid arthritis?
Early initiation of effective pharmacotherapy with DMARDs, biologics, and rarely steroids is recommended for a treat to target therapy. The main aim is to attain clinical remission or low disease activity through frequent monitoring of disease activity. Biologicals need to be initiated in patients with inadequate treatment responses.
To learn more, watch the lecture on immunomodulators in rheumatoid arthritis given by Dr. Ashwini Kamath.